This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1756285609104792v1 2/4/261    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lehmann, H. C Articles by Hartung, H.-P. Search for Related Content Social Bookmarking                         What's this?

Pathogenesis and treatment of immune-mediated neuropathies

Heinrich-Heine-University

^* To whom correspondence should be addressed. E-mail: hans-peter.hartung{at}uni-duesseldorf.de.

	Abstract

Immune-mediated neuropathies represent a heterogeneous spectrum of peripheral nerve disorders that can be classified according to time course, predominant involvement of motor/sensory fibers, distribution of deficits and paraclinical parameters such as electrophysiology and serum antibodies. In the last few years, significant advances have been achieved in elucidating underlying pathomechanisms, which made it possible to identify potential therapeutic targets. In this review, we discuss the latest development in pathogenesis and treatment of immune-mediated neuropathies.

First published on May 28, 2009, doi:10.1177/1756285609104792

Therapeutic Advances in Neurological Disorders 2009;2:261.

A more recent version of this article appeared on July 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?